GV 2021 Gp, L.P., 10% Owner at Prime Medicine, Inc. (PRME), sold 257,854 shares at $13.01 ($2.5M) on 2023-05-18, disclosed to the SEC on 2023-05-22.
Scheduled sale ($2.5M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 14,022 | $0 | 0.0% |
| 2 | $13.01 | 13,076 | $170K | 6.9% |
| 3 | $13.01 | 13,076 | $170K | 6.9% |
| 4 | $13.06 | 14,022 | $183K | 7.4% |
| 5 | $13.06 | 14,022 | $183K | 7.4% |
| 6 | $0.00 | 63,212 |
| $0 |
| 0.0% |
| 7 | $13.88 | 63,212 | $877K | 35.6% |
| 8 | $13.88 | 63,212 | $877K | 35.6% |
| Total | $9.55 avg | 257,854 | $2.5M | 100% |
| Filing → |
| PRME | SELL | 2023-06-09 | $586K | — | Filing → |
| PRME | SELL | 2023-06-07 | $1.8M | — | Filing → |
| PRME | SELL | 2023-05-10 | $11.9M | — | Filing → |